Tissue engineering bone formation in novel recombinant human bone morphogenic protein 2-atelocollagen composite scaffolds

Journal of Periodontology

Volumn 78, Issue 2, 2007, Pages 335-343

  Hou, Lein Tuan ^a,b   Liu, Cheng Meei ^b   Liu, Bu Yuan ^a   Chang, Po Chun ^a   Chen, Min Huei ^a   Ho, Ming Hua ^c   Jehng, Su Min ^b   Liu, Hwa Chang ^b  

^a NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^c NATIONAL TAIWAN UNIVERSITY   (Taiwan)

Author keywords

Bone morphogenic protein; Bone sialoprotein; Osteopontin; Tissue engineering

Indexed keywords

ATELOCOLLAGEN; BONE MORPHOGENETIC PROTEIN; BONE SIALOPROTEIN; COLLAGEN; DRUG CARRIER; OSTEOCALCIN; OSTEOPONTIN; RECOMBINANT HUMAN BONE MORPHOGENETIC PROTEIN 2; RECOMBINANT HUMAN BONE MORPHOGENETIC PROTEIN-2; RECOMBINANT PROTEIN; SIALOGLYCOPROTEIN; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG;

ANIMAL; ARTICLE; BIODEGRADABLE IMPLANT; BIOSYNTHESIS; BONE DEVELOPMENT; CHONDROGENESIS; ENZYME IMMUNOASSAY; EVALUATION; FEASIBILITY STUDY; HUMAN; IMPLANT; METABOLISM; METHODOLOGY; OSTEOBLAST; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TISSUE ENGINEERING; WISTAR RAT;

ABSORBABLE IMPLANTS; ANIMALS; BONE MORPHOGENETIC PROTEINS; CHONDROGENESIS; COLLAGEN; DRUG CARRIERS; FEASIBILITY STUDIES; HUMANS; IMMUNOENZYME TECHNIQUES; IMPLANTS, EXPERIMENTAL; OSTEOBLASTS; OSTEOCALCIN; OSTEOGENESIS; OSTEOPONTIN; RATS; RATS, WISTAR; RECOMBINANT PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SIALOGLYCOPROTEINS; TISSUE ENGINEERING; TRANSFORMING GROWTH FACTOR BETA;

EID: 33847790158     PISSN: 00223492     EISSN: None     Source Type: Journal    
DOI: 10.1902/jop.2007.060106     Document Type: Article

References (61)

1. Bonassar LJ, Vacanti CA. Tissue engineering: The first decade and beyond. J Cell Biochem Suppl 1998; 30-31:297-303.
2. Urist MR. Bone: Formation by autoinduction. Science 1965; 150:893-899.
3. Huggins C, Wiseman S, Reddi AH. Transformation of fibroblasts by allogeneic and xenogeneic transplants of demineralized tooth and bone. J Exp Med 1970;132: 1250-1258.
4. Wang EA, Rosen VD, Alessandro JS, et al. Recombinant human bone morphogenetic protein induces bone formation. Proc Natl Acad Sci USA 1990;87: 2220-2224.
5. Chakkalakal DA, Strates BS, Garvin KL, et al. Demineralized bone matrix as a biological scaffold for bone repair. Tissue Eng 2001;7:161-177.
6. Snyder A, Fraser ST, Baron MH. Bone morphogenetic proteins in vertebrate hematopoietic development. J Cell Biochem 2004;93:224-232.
7. Bessho K, Kusumoto K, Fujimura K, et al. Comparison of recombinant and purified human bone morphogenetic protein. Br J Oral Maxillofac Surg 1999;37:2-5.
8. Wozney JM, Rosen V, Celeste AJ, et al. Novel regulators of bone formation: Molecular clones and activities. Science 1988;242:1528-1534.
9. Sigurdsson TJ, Nygaard L, Tatakis DN, et al. Periodontal repair in dogs: Evaluation of rhBMP-2 carriers. Int J Periodontics Restorative Dent 1996;16: 524-537.
10. Uludag H, D'Augusta D, Palmer R, Timony G, Wozney JM. Characterization of rhBMP-2 pharmacokinetics implanted with biomaterial carriers in the rat ectopic model. J Biomed Mater Res 1999;46:193-202.
11. Ripamonti U, Crooks J, Petit JC, Rueger DC. Periodontal tissue regeneration by combined applications of recombinant human osteogenic protein- 1 and bone morphogenetic protein-2. A pilot study in Chacma baboons (Papio ursinus). Eur J Oral Sci 2001;109: 241-248.
12. Cochran DL, Jones AA, Lilly LC, Fiorellini JP, Howell H. Evaluation of recombinant human bone morphogenetic protein-2 in oral applications including the use of endosseous implants: 3-year results of a pilot study in humans. J Periodontol 2000;71:1241-1257.
13. van den Bergh JPA, ten Bruggenkate CM, Groeneveld HHJ, Burger EH, Tuinzing DB. Recombinant human bone morphogenetic protein-7 in maxillary sinus floor elevation surgery in 3 patients compared to autogenous bone grafts. A clinical pilot study. J Clin Periodontol 2000;27:627-636.
14. Geiger M, Li RH, Friess W. Collagen sponges for bone regeneration with rhBMP-2. Adv Drug Deliv Rev 2003; 55:1613-1629.
15. Jung RE, Glauser R, Scharer P, Hammerle CH, Sailer HF, Weber FE. Effect of rhBMP-2 on guided bone regeneration in humans. Clin Oral Implants Res 2003; 14:556-568.
16. Fiorellini JP, Howell TH, Cochran D, et al. Randomized study evaluating recombinant human bone morphogenetic protein-2 for extraction socket augmentation. J Periodontol 2005;76:605-613.
17. Miyamoto S, Takaoka K, Okada T, et al. Evaluation of polylactic acid homopolymers as carrier for bone morphogenetic protein. Clin Orthop 1992;278:274-286.
18. Lam KH, Schakenraad JM, Esselbrugge H, Feijen J, Nieuwenhuis P. The effect of phagocytosis of poly (L-lactic acid) fragments on cellular morphology and viability. J Biomed Mater Res 1993;27:1569-1577.
19. Boss JH. Biocompatibility: Review of the concept and its relevance to clinical practice. In: Wise DL, ed. Biomaterials and Bioengineering Handbook. New York: Marcel Dekker; 2000:46-52.
20. King GN, Cochran DL. Factors that modulate the effects of bone morphogenetic protein-induced periodontal regeneration: A critical review. J Periodontol 2002;73:925-936.
21. Yang C, Hillas PJ, Baez JA, et al. The application of recombinant human collagen in tissue engineering. BioDrugs 2004; 18:103-119.
22. Xiao Y, Qian H, Young WG, Bartold PM. Tissue engineering for bone regeneration using differentiated alveolar bone cells in collagen scaffolds. Tissue Eng 2003;9:1167-1177.
23. Juncosa-Melvin N, Boivin GP, Galloway MT, et al. Effects of cell-to-collagen ratio in mesenchymal stem cell-seeded implants on tendon repair. Tissue Eng 2005; 11:448-457.
24. Gersbach CA, Byers BA, Pavlath GK, Guldberg RE, Garcia AJ. Runx2/Cbfa1 -genetically engineered skeletal myoblasts mineralize collagen scaffolds in vitro. Biotechnol Bioeng 2004;88:369-378.
25. Song E, Kim SY, Chun T, Byun HJ, Lee YM. Collagen scaffolds derived from a marine source and their biocompatibility. Biomaterials 2006;27:2951-2961.
26. Pontz B, Meigel W, Rauterberg J, Kuhn K. Localization of two species antigenic determinations on the peptide chains of calf skin collagen. Eur J Biochem 1970; 16: 50-54.
27. Furthmayr H, Timpl R. Immunochemistry of collagens and procollegans. Int Rev Connect Tissue Res 1976;7: 61-99.
28. Delustro F, Condell RA, Nguyen MA, McPherson JM. A comparative study of the biologic and immunologic response to medical devices derived from dermal collagen. J Biomed Mater Res 1986;20:109-120.
29. Charriere G, Bejot M, Schnitzler L, Ville G, Hartmann DJ. Reactions to a bovine collagen implant. Clinical and immunologic study in 705 patients. J Am Acad Dermatol 1989;21:1203-1208.
30. Stenzel KH, Miyata T, Rubin AL. Collagen as a bio-material. Annu Rev Biophys Bioeng 1974;3:231-253.
31. Kusumoto K, Bessho K, Fujimura K, Konishi Y, Ogawa Y, Iizuka T. Self-regenerating bone implant: Ectopic osteoinduction following intramuscular implantation of a combination of rhBMP-2, atelopeptide type I collagen and porous hydroxyapatite. J Craniomaxillofac Surg 1996;24:360-365.
32. Itoh H, Aso Y, Furuse M, Noishiki Y, Miyata T. A honeycomb collagen carrier for cell culture as a tissue engineering scaffold. Artif Organs 2001;25:213-217.
33. Miyata T, Taira T, Noishiki Y. Collagen engineering for biomaterial use. Clin Mater 1992;9:139-148.
34. Masuoka K, Asazuma T, Ishihara M, et al. Tissue engineering of articular cartilage using an allograft of cultured chondrocytes in a membrane-sealed atelocollagen honeycomb-shaped scaffold (ACHMS scaffold). J Biomed Mater Res Part B Appl Biomater 2005; 75:177-184.
35. Lian JB, McKee MD, Todd AM, Gerstenfeld LC. Induction of bone-related proteins, osteocalcin and osteopontin, and their matrix ultrastructural localization with development of chondrocyte hypertrophy in vitro. J Cell Biochem 1993;52:206-219.
36. Bianco P, Fisher LW, Young MF, Termine JD, Robey PG. Expression of bone sialoprotein in developing human tissues. Calcif Tissue Int 1991;49:421-426.
37. Shukunami C, Ohta Y, Sakuda M, Hiraki Y. Sequential progression of the differentiation program by bone morphogenetic protein-2 in chondrogenic cell line ATDC5. Exp Cell Res 1998;241:1-11.
38. Boyan BD, Lohmann CH, Somers A, et al. Potential of porous poly-d,L-lactide-co-glycolide particles as a carrier for recombinant human bone morphogenetic protein-2 during osteoinduction in vivo. J Biomed Mater Res 1999;46:51-59.
39. Fujimura K, Bessho K, Kusumoto K, Ogawa Y, Iizuka T. Experimental studies on bone inducing activity of composites of atelopeptide type I collagen as a carrier for ectopic osteoinduction by rhBMP-2. Biochem Biophys Res Commun 1995;208:316-322.
40. Gruber HE. Adaptation of Goldner's Masson trichrome stain for the study of undecalcified plastic embedded bone. Biotech Histochem 1992;67:30-34.
41. Piattelli A, Trisi P, Passi P, Piattelli M, Cordioli GP. Histochemical and confocal laser scanning microscopy study of the bone-titanium interface: An expermental study in rabbits. Biomaterials 1994;15: 194-200.
42. An YH, Woolf SK, Friedman RJ. Pre-clinical in vivo evaluation of orthopaedic bioabsorbable devices. Biomaterials 2000;21:2635-2652.
43. Ho MH, Wang DM, Hsieh HJ, et al. Preparation and characterization of RGD-immobilized chitosan scaffolds. Biomaterials 2005;26:3197-3206.
44. Fujioka K, Maeda M, Hojo T, Sano A. Protein release from collagen matrices. Adv Drug Deliv Rev 1998;31: 247-266.
45. Vizarova K, Bakos D, Rehakova M, Petrikova M, Panakova E, Koller J. Modification of layered atelocollagen: Enzymatic degradation and cytotoxicity evaluation. Biomaterials 1995;16:1217-1221.
46. Rousseau CF, Gagnieu CH. In vitro cytocompatibility of porcine type I atelocollagen crosslinked by oxidized glycogen. Biomaterials 2002;23:1503-1510.
47. Ochiya T, Nagahara S, Sano A, Itou H, Terata M. Biomaterials for gene delivery: Atelocollagen-mediated controlled release of molecular medicines. Curr Gene Ther 2001; 1:31-52.
48. Uchio Y, Ochi M, Matsusaki M, Kurioka H, Katsube K. Human chondrocyte proliferation and matrix synthesis cultured in atelocollagen gel. J Biomed Mater Res 2000;50:138-143.
49. Hanai K, Kurokawa T, Minakuchi Y, et al. Potential of atelocollagen-mediated systemic antisense therapeutics for inflammatory disease. Hum Gene Ther 2004; 15: 263-272.
50. Sachlos E, Reis N, Ainsley C, Derby B, Czernuszka JT. Novel collagen scaffolds with pre-defined internal morphology made by solid freedom fabrication. Biomaterials 2003;24:1487-1497.
51. Tsujigiwa H, Nagatsuka H, Gunduz M, et al. Effects of immobilized recombinant human bone morphogenetic protein-2/succinylated type I atelocollagen on cellular activity of ST2 cells. J Biomed Mater Res A 2005;75: 210-215.
52. Wikesjö UME, Sorensen RG, Wozney JM. Augmentation of alveolar bone and dental implant osseointegration: Clinical implications of studies with rhBMP-2. J Bone Joint Surg Am 2001;83-A(Suppl. 1):S136-S145.
53. Reddi AH, Muthukumaran N. Biologic principles of bone induction. Orthop Clin North Am 1987; 18:207-212.
54. Aubin JE, Liu F, Malaval L, Gupta AK. Osteoblast and chondroblast differentiation. Bone 1995;17(2 Suppl): 77S-83S.
55. Bunyaratavej P, Hullinger TG, Somerman MJ. Bone morphogenetic proteins secreted by breast cancer cells upgrade bone sialoprotein expression in preosteoblast cells. Exp Cell Res 2000;260:324-333.
56. Lynn AK, Yannas IV, Bonfield W. Antigenicity and immunogenicity of collagen. J Biomed Mater Res Part B Appl Biomater 2004;71:343-354.
57. Winn SR, Schmitt JM, Buck D, Hu YH, Grainger D, Hollinger JO. Tissue-engineered bone biomimetic to regenerate calvarial critical-sized defects in athymic rats. J Biomed Mater Res 1999;45:414-421.
58. Suh H, Hwang YS, Lee JE, Han CD, Park JC. Behavior of osteoblasts on a type I atelocollagen grafted ozone oxidized poly L-lactic acid membrane. Biomaterials 2001;22:219-230.
59. Okubo Y, Bessho K, Fujimura K, et al. Osteoinduction by recombinant human bone morphogenetic protein-2 at intramuscular, intermuscular, and intra-fatty sites. Int J Oral Maxillofac Surg 2000;29:62-66.
60. Kodama T. The histopathological study of periodontal tissue regeneration using atelocollagen membrane (in Japanese). Nippon Shishubyo Gakkai Kaishi 1990; 32:1-25.
61. Numabe Y, Ito H, Hayashi H, Ryder MI, Kamoi K. Epithelial cell kinetics with atelocollagen membranes: A study in rats. J Periodontol 1993;64:706-712.